Review Avnet's (AVT) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.

New Strong Sell Stocks for August 11th

08:51am, Monday, 11'th Aug 2025
AVT, BDORY and DIN have been added to the Zacks Rank #5 (Strong Sell) List on August 11, 2025.
AVT tops Q4 estimates, but shares plunge 4.7% as weak profit guidance for Q1 FY26 overshadows the beat.

Avnet (AVT) Q4 Revenue Rises 1%

05:33pm, Wednesday, 06'th Aug 2025
Avnet (AVT -4.68%), a global distributor of electronic components and embedded solutions, reported Q4 FY2025 results on August 6, 2025. The company delivered GAAP revenue of $5,617.8 million.

Avnet, Inc. (AVT) Q4 2025 Earnings Call Transcript

02:31pm, Wednesday, 06'th Aug 2025
Avnet, Inc. (NASDAQ:AVT ) Q4 2025 Earnings Conference Call August 6, 2025 12:00 PM ET Company Participants Joseph Burke - Vice President of Treasury & Investor Relations Kenneth A. Jacobson - Chief Fi
Although the revenue and EPS for Avnet (AVT) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street esti
Avnet (AVT) came out with quarterly earnings of $0.81 per share, beating the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $1.22 per share a year ago.
PHOENIX--(BUSINESS WIRE)-- #Avnet--Avnet reports fourth quarter and fiscal 2025 financial results.
PHOENIX--(BUSINESS WIRE)-- #Avnet--Avnet to participate in the KeyBanc Technology Leadership Forum on August 12.
PHOENIX--(BUSINESS WIRE)-- #Avnet--Avnet to report fourth quarter and fiscal year 2025 earnings on August 6 and to hold annual shareholder meeting on November 21.
Avnet remains a Hold as sluggish OEM demand and high inventory persist, but signs of stability are emerging, especially in Asia. Q3 2025 results were unremarkable but solid, with strong cash flow, sta
REYKJAVIK,  ICELAND and LONDON, UK (June 23, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide
REYKJAVIK, Iceland and LONDON, June 23, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients
Avnet (AVT) reported earnings 30 days ago. What's next for the stock?

Avnet Declares Regular Quarterly Dividend

08:00pm, Wednesday, 14'th May 2025
PHOENIX--(BUSINESS WIRE)-- #Avnet--Avnet declares regular quarterly dividend.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE